$PDLI Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in PDL BIOPHARMA, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in PDL BIOPHARMA, INC.. Get notifications about new insider transactions in PDL BIOPHARMA, INC. for free.
Page: < prev 1 ... 3 4 5 6 7 8 9 10 11 ... 11 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 10 2006 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Buy | M | 8.30 | 10,000 | 83,000 | 70,000 | 60 K to 70 K (+16.67 %) |
Jan 09 2006 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Sell | S | 30.00 | 5,000 | 150,000 | 82,680 | 87.7 K to 82.7 K (-5.70 %) |
Jan 06 2006 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Option Exercise | M | 13.29 | 2,187 | 29,065 | 50,313 | |
Jan 06 2006 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Sell | S | 28.92 | 2,187 | 63,248 | 12,500 | 14.7 K to 12.5 K (-14.89 %) |
Jan 06 2006 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Buy | M | 13.29 | 2,187 | 29,065 | 14,687 | 12.5 K to 14.7 K (+17.50 %) |
Jan 09 2006 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Option Exercise | M | 8.30 | 10,000 | 83,000 | 670,000 | |
Jan 09 2006 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 29.72 | 10,000 | 297,210 | 60,000 | 70 K to 60 K (-14.29 %) |
Jan 09 2006 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Buy | M | 8.30 | 10,000 | 83,000 | 70,000 | 60 K to 70 K (+16.67 %) |
Jan 06 2006 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Option Exercise | M | 8.30 | 10,000 | 83,000 | 680,000 | |
Jan 06 2006 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 28.70 | 10,000 | 287,040 | 60,000 | 70 K to 60 K (-14.29 %) |
Jan 06 2006 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Buy | M | 8.30 | 10,000 | 83,000 | 70,000 | 60 K to 70 K (+16.67 %) |
Jan 06 2006 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Sell | S | 30.03 | 5,000 | 150,150 | 87,680 | 92.7 K to 87.7 K (-5.39 %) |
Jan 05 2006 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Option Exercise | A | 28.44 | 15,000 | 426,600 | 15,000 | |
Jan 05 2006 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Option Exercise | M | 8.30 | 10,000 | 83,000 | 690,000 | |
Jan 05 2006 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Sell | S | 28.01 | 10,000 | 280,102 | 60,000 | 70 K to 60 K (-14.29 %) |
Jan 05 2006 | PDLI | PDL BIOPHARMA, INC ... | MCDADE MARK | CEO | Buy | M | 8.30 | 10,000 | 83,000 | 70,000 | 60 K to 70 K (+16.67 %) |
Mar 31 2006 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Sell | S | 32.01 | 358 | 11,460 | 21,680 | 22 K to 21.7 K (-1.62 %) |
Mar 31 2006 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Sell | S | 32.00 | 4,642 | 148,544 | 22,038 | 26.7 K to 22 K (-17.40 %) |
Mar 29 2006 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Sell | S | 31.25 | 5,000 | 156,244 | 26,680 | 31.7 K to 26.7 K (-15.78 %) |
Mar 28 2006 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales O ... | Option Exercise | M | 15.73 | 26,250 | 412,913 | 78,750 | |
Mar 28 2006 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales O ... | Sell | S | 31.66 | 26,250 | 831,028 | 0 | 26.3 K to 0 (-100.00 %) |
Mar 28 2006 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales O ... | Buy | M | 15.73 | 26,250 | 412,913 | 26,250 | 0 to 26.3 K |
Mar 22 2006 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Sell | S | 32.23 | 5,000 | 161,173 | 31,680 | 36.7 K to 31.7 K (-13.63 %) |
Mar 22 2006 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Sell | S | 32.24 | 5,000 | 161,190 | 36,680 | 41.7 K to 36.7 K (-12.00 %) |
Mar 15 2006 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Sell | S | 32.04 | 5,000 | 160,212 | 41,680 | 46.7 K to 41.7 K (-10.71 %) |
Mar 15 2006 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Sell | S | 31.40 | 5,000 | 157,018 | 46,680 | 51.7 K to 46.7 K (-9.67 %) |
Mar 15 2006 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales O ... | Option Exercise | M | 21.73 | 177 | 3,846 | 7,084 | |
Mar 15 2006 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales O ... | Sell | S | 32.00 | 177 | 5,664 | 0 | 177 to 0 (-100.00 %) |
Mar 15 2006 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales O ... | Buy | M | 21.73 | 177 | 3,846 | 177 | 0 to 177 |
Mar 10 2006 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales O ... | Sell | S | 32.50 | 277 | 9,003 | 0 | 277 to 0 (-100.00 %) |
Mar 10 2006 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Sell | S | 32.80 | 40,000 | 1,312,000 | 233,178 | 273.2 K to 233.2 K (-14.64 %) |
Mar 10 2006 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Sell | S | 32.33 | 400 | 12,932 | 273,178 | 273.6 K to 273.2 K (-0.15 %) |
Mar 10 2006 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Sell | S | 32.32 | 1,300 | 42,016 | 273,578 | 274.9 K to 273.6 K (-0.47 %) |
Mar 10 2006 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Sell | S | 32.31 | 10,000 | 323,100 | 274,878 | 284.9 K to 274.9 K (-3.51 %) |
Mar 10 2006 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Sell | S | 32.30 | 28,300 | 914,090 | 284,878 | 313.2 K to 284.9 K (-9.04 %) |
Mar 10 2006 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Sell | S | 32.12 | 5,000 | 160,620 | 51,680 | 56.7 K to 51.7 K (-8.82 %) |
Mar 08 2006 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Sell | S | 31.37 | 5,000 | 156,835 | 56,680 | 61.7 K to 56.7 K (-8.11 %) |
Mar 08 2006 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Option Exercise | M | 13.29 | 2,187 | 29,065 | 45,938 | |
Mar 08 2006 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Sell | S | 31.20 | 2,187 | 68,234 | 12,500 | 14.7 K to 12.5 K (-14.89 %) |
Mar 08 2006 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Buy | M | 13.29 | 2,187 | 29,065 | 14,687 | 12.5 K to 14.7 K (+17.50 %) |
Mar 07 2006 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Option Exercise | M | 15.25 | 1,875 | 28,594 | 39,688 | |
Mar 07 2006 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Option Exercise | M | 7.85 | 13,125 | 103,031 | 30,625 | |
Mar 07 2006 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Sell | S | 32.02 | 1,875 | 60,038 | 39,020 | 40.9 K to 39 K (-4.58 %) |
Mar 07 2006 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Buy | M | 15.25 | 1,875 | 28,594 | 40,895 | 39 K to 40.9 K (+4.81 %) |
Mar 07 2006 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Sell | S | 32.02 | 452 | 14,473 | 39,020 | 39.5 K to 39 K (-1.15 %) |
Mar 07 2006 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Buy | M | 7.85 | 452 | 3,548 | 39,472 | 39 K to 39.5 K (+1.16 %) |
Mar 07 2006 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Sell | S | 32.00 | 12,673 | 405,536 | 39,020 | 51.7 K to 39 K (-24.52 %) |
Mar 07 2006 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Buy | M | 7.85 | 12,673 | 99,483 | 51,693 | 39 K to 51.7 K (+32.48 %) |
Mar 07 2006 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales O ... | Option Exercise | M | 21.73 | 1,239 | 26,923 | 7,261 | |
Mar 07 2006 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales O ... | Sell | S | 32.00 | 1,239 | 39,648 | 277 | 1.5 K to 277 (-81.73 %) |
Mar 07 2006 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales O ... | Buy | M | 21.73 | 1,239 | 26,923 | 1,516 | 277 to 1.5 K (+447.29 %) |
Mar 07 2006 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Sell | S | 32.00 | 5,000 | 160,000 | 61,680 | 66.7 K to 61.7 K (-7.50 %) |
Mar 07 2006 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Sell | S | 31.82 | 1,200 | 38,184 | 313,178 | 314.4 K to 313.2 K (-0.38 %) |
Mar 07 2006 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Sell | S | 31.80 | 13,800 | 438,840 | 314,378 | 328.2 K to 314.4 K (-4.21 %) |
Mar 03 2006 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Sell | S | 31.80 | 24,820 | 789,301 | 328,178 | 353 K to 328.2 K (-7.03 %) |
Mar 02 2006 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Sell | S | 31.80 | 180 | 5,724 | 352,998 | 353.2 K to 353 K (-0.05 %) |
Mar 01 2006 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Sell | S | 30.71 | 5,000 | 153,530 | 66,680 | 71.7 K to 66.7 K (-6.98 %) |
Feb 28 2006 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Sell | S | 30.00 | 5,000 | 150,000 | 71,680 | 76.7 K to 71.7 K (-6.52 %) |
Feb 15 2006 | PDLI | PDL BIOPHARMA, INC ... | Iwanicki David | VP, Sales & Sales O ... | Option Exercise | A | 21.73 | 8,500 | 184,705 | 8,500 | |
Feb 08 2006 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Option Exercise | M | 13.29 | 2,188 | 29,079 | 48,125 | |
Feb 08 2006 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Sell | S | 29.25 | 2,188 | 63,999 | 12,500 | 14.7 K to 12.5 K (-14.90 %) |
Feb 08 2006 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Buy | M | 13.29 | 2,188 | 29,079 | 14,688 | 12.5 K to 14.7 K (+17.50 %) |
Dec 28 2005 | PDLI | PDL BIOPHARMA, INC ... | QUEEN CARY L | Director | Option Exercise | M | 6.63 | 10,000 | 66,250 | 30,000 | |
Dec 28 2005 | PDLI | PDL BIOPHARMA, INC ... | QUEEN CARY L | Director | Sell | S | 30.00 | 15,000 | 450,000 | 1,961,800 | 2 M to 2 M (-0.76 %) |
Dec 28 2005 | PDLI | PDL BIOPHARMA, INC ... | QUEEN CARY L | Director | Buy | M | 6.63 | 10,000 | 66,250 | 1,976,800 | 2 M to 2 M (+0.51 %) |
Dec 28 2005 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Sell | S | 30.00 | 10,000 | 300,000 | 92,680 | 102.7 K to 92.7 K (-9.74 %) |
Dec 07 2005 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Option Exercise | M | 13.29 | 2,188 | 29,079 | 52,500 | |
Dec 07 2005 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Sell | S | 27.92 | 2,188 | 61,089 | 12,500 | 14.7 K to 12.5 K (-14.90 %) |
Dec 07 2005 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Buy | M | 13.29 | 2,188 | 29,079 | 14,688 | 12.5 K to 14.7 K (+17.50 %) |
Nov 08 2005 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Option Exercise | M | 13.29 | 2,187 | 29,065 | 54,688 | |
Nov 08 2005 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Sell | S | 26.30 | 2,187 | 57,518 | 12,500 | 14.7 K to 12.5 K (-14.89 %) |
Nov 08 2005 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Buy | M | 13.29 | 2,187 | 29,065 | 14,687 | 12.5 K to 14.7 K (+17.50 %) |
Nov 04 2005 | PDLI | PDL BIOPHARMA, INC ... | LINK MAX | Director | Option Exercise | M | 18.28 | 9,916 | 181,264 | 39,084 | |
Nov 04 2005 | PDLI | PDL BIOPHARMA, INC ... | LINK MAX | Director | Option Exercise | M | 15.25 | 25,000 | 381,250 | 0 | |
Nov 04 2005 | PDLI | PDL BIOPHARMA, INC ... | LINK MAX | Director | Option Exercise | M | 19.13 | 18,000 | 344,340 | 0 | |
Nov 04 2005 | PDLI | PDL BIOPHARMA, INC ... | LINK MAX | Director | Option Exercise | M | 13.55 | 3,000 | 40,650 | 0 | |
Nov 04 2005 | PDLI | PDL BIOPHARMA, INC ... | LINK MAX | Director | Option Exercise | M | 15.35 | 4,000 | 61,400 | 0 | |
Nov 04 2005 | PDLI | PDL BIOPHARMA, INC ... | LINK MAX | Director | Buy | M | 18.28 | 9,916 | 181,264 | 159,916 | 150 K to 159.9 K (+6.61 %) |
Nov 04 2005 | PDLI | PDL BIOPHARMA, INC ... | LINK MAX | Director | Buy | M | 15.25 | 25,000 | 381,250 | 150,000 | 125 K to 150 K (+20.00 %) |
Nov 04 2005 | PDLI | PDL BIOPHARMA, INC ... | LINK MAX | Director | Buy | M | 19.13 | 18,000 | 344,340 | 125,000 | 107 K to 125 K (+16.82 %) |
Nov 04 2005 | PDLI | PDL BIOPHARMA, INC ... | LINK MAX | Director | Buy | M | 13.55 | 3,000 | 40,650 | 107,000 | 104 K to 107 K (+2.88 %) |
Nov 04 2005 | PDLI | PDL BIOPHARMA, INC ... | LINK MAX | Director | Buy | M | 15.35 | 4,000 | 61,400 | 104,000 | 100 K to 104 K (+4.00 %) |
Oct 20 2005 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Sell | S | 30.27 | 5,000 | 151,352 | 102,680 | 107.7 K to 102.7 K (-4.64 %) |
Oct 12 2005 | PDLI | PDL BIOPHARMA, INC ... | Calcott Peter H | VP, Quality & Compl ... | Grant | A | 0.00 | 2,500 | 0 | 2,500 | 0 to 2.5 K |
Oct 06 2005 | PDLI | PDL BIOPHARMA, INC ... | QUEEN CARY L | Director | Sell | S | 30.00 | 3,000 | 90,000 | 1,966,800 | 2 M to 2 M (-0.15 %) |
Oct 06 2005 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Option Exercise | M | 13.29 | 2,188 | 29,079 | 56,875 | |
Oct 06 2005 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Sell | S | 29.30 | 2,188 | 64,108 | 12,500 | 14.7 K to 12.5 K (-14.90 %) |
Oct 06 2005 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Buy | M | 13.29 | 2,188 | 29,079 | 14,688 | 12.5 K to 14.7 K (+17.50 %) |
Oct 03 2005 | PDLI | PDL BIOPHARMA, INC ... | DAWES KAREN A | Director | Option Exercise | A | 27.87 | 3,000 | 83,610 | 3,000 | |
Oct 03 2005 | PDLI | PDL BIOPHARMA, INC ... | SAXE JON S | Director | Option Exercise | A | 27.87 | 3,000 | 83,610 | 3,000 | |
Oct 03 2005 | PDLI | PDL BIOPHARMA, INC ... | Broder Samuel | Director | Option Exercise | A | 27.87 | 3,000 | 83,610 | 3,000 | |
Oct 03 2005 | PDLI | PDL BIOPHARMA, INC ... | Broder Samuel | Director | Option Exercise | A | 27.87 | 3,000 | 83,610 | 3,000 | |
Oct 03 2005 | PDLI | PDL BIOPHARMA, INC ... | Broder Samuel | Director | Option Exercise | A | 27.87 | 15,000 | 418,050 | 15,000 | |
Sep 16 2005 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Sell | S | 30.30 | 35,000 | 1,060,500 | 423,178 | 458.2 K to 423.2 K (-7.64 %) |
Sep 16 2005 | PDLI | PDL BIOPHARMA, INC ... | QUEEN CARY L | Director | Sell | S | 30.00 | 3,000 | 90,000 | 1,969,800 | 2 M to 2 M (-0.15 %) |
Sep 08 2005 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Option Exercise | M | 15.25 | 3,437 | 52,414 | 41,563 | |
Sep 08 2005 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Option Exercise | M | 7.85 | 6,563 | 51,520 | 43,750 | |
Sep 08 2005 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Sell | S | 28.99 | 1,200 | 34,788 | 39,020 | 40.2 K to 39 K (-2.98 %) |
Sep 08 2005 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Sell | S | 28.75 | 2,237 | 64,314 | 40,220 | 42.5 K to 40.2 K (-5.27 %) |
Sep 08 2005 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Sell | S | 28.75 | 5,863 | 168,561 | 42,457 | 48.3 K to 42.5 K (-12.13 %) |
Sep 08 2005 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Sell | S | 28.74 | 100 | 2,874 | 48,320 | 48.4 K to 48.3 K (-0.21 %) |
Sep 08 2005 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Sell | S | 28.73 | 500 | 14,365 | 48,420 | 48.9 K to 48.4 K (-1.02 %) |
Sep 08 2005 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Sell | S | 28.72 | 100 | 2,872 | 48,920 | 49 K to 48.9 K (-0.20 %) |
Sep 08 2005 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Buy | M | 15.25 | 3,437 | 52,414 | 49,020 | 45.6 K to 49 K (+7.54 %) |
Sep 08 2005 | PDLI | PDL BIOPHARMA, INC ... | MURRAY RICHARD /CA/ | Sr. VP & CSO | Buy | M | 7.85 | 6,563 | 51,520 | 45,583 | 39 K to 45.6 K (+16.82 %) |
Sep 08 2005 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Option Exercise | M | 13.29 | 2,187 | 29,065 | 59,063 | |
Sep 08 2005 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Sell | S | 28.66 | 2,187 | 62,679 | 12,500 | 14.7 K to 12.5 K (-14.89 %) |
Sep 08 2005 | PDLI | PDL BIOPHARMA, INC ... | TORRES LAURIE C | VP, Human Resources | Buy | M | 13.29 | 2,187 | 29,065 | 14,687 | 12.5 K to 14.7 K (+17.50 %) |
Sep 08 2005 | PDLI | PDL BIOPHARMA, INC ... | SCHMIDLI BRETT L | SVP, Technical Oper ... | Option Exercise | M | 7.83 | 18,000 | 140,940 | 12,000 | |
Sep 08 2005 | PDLI | PDL BIOPHARMA, INC ... | SCHMIDLI BRETT L | SVP, Technical Oper ... | Sell | S | 29.01 | 18,000 | 522,108 | 2,500 | 20.5 K to 2.5 K (-87.80 %) |
Sep 08 2005 | PDLI | PDL BIOPHARMA, INC ... | SCHMIDLI BRETT L | SVP, Technical Oper ... | Buy | M | 7.83 | 18,000 | 140,940 | 20,500 | 2.5 K to 20.5 K (+720.00 %) |
Sep 08 2005 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Option Exercise | M | 18.90 | 60,000 | 1,134,000 | 240,000 | |
Sep 08 2005 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Option Exercise | M | 9.66 | 55,416 | 535,114 | 0 | |
Sep 08 2005 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Sell | S | 28.37 | 30,000 | 850,986 | 458,178 | 488.2 K to 458.2 K (-6.15 %) |
Sep 08 2005 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Sell | S | 29.32 | 30,000 | 879,630 | 488,178 | 518.2 K to 488.2 K (-5.79 %) |
Sep 08 2005 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Sell | S | 28.80 | 30,000 | 864,018 | 518,178 | 548.2 K to 518.2 K (-5.47 %) |
Sep 08 2005 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Sell | S | 29.80 | 35,000 | 1,043,000 | 548,178 | 583.2 K to 548.2 K (-6.00 %) |
Sep 08 2005 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Sell | S | 28.40 | 40,000 | 1,136,112 | 583,178 | 623.2 K to 583.2 K (-6.42 %) |
Sep 08 2005 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Sell | S | 28.94 | 40,000 | 1,157,404 | 623,178 | 663.2 K to 623.2 K (-6.03 %) |
Sep 08 2005 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Sell | S | 27.99 | 35,416 | 991,443 | 663,178 | 698.6 K to 663.2 K (-5.07 %) |
Sep 08 2005 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Buy | M | 18.90 | 60,000 | 1,134,000 | 698,594 | 638.6 K to 698.6 K (+9.40 %) |
Sep 08 2005 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Buy | M | 9.66 | 55,416 | 535,114 | 638,594 | 583.2 K to 638.6 K (+9.50 %) |
Sep 02 2005 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Option Exercise | M | 9.66 | 30,000 | 289,689 | 55,416 | |
Sep 02 2005 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Sell | S | 26.60 | 10,000 | 266,000 | 583,178 | 593.2 K to 583.2 K (-1.69 %) |
Sep 02 2005 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Sell | S | 26.58 | 10,000 | 265,750 | 593,178 | 603.2 K to 593.2 K (-1.66 %) |
Sep 02 2005 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Sell | S | 26.50 | 10,000 | 265,000 | 603,178 | 613.2 K to 603.2 K (-1.63 %) |
Sep 02 2005 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Sell | S | 26.36 | 10,000 | 263,600 | 613,178 | 623.2 K to 613.2 K (-1.60 %) |
Sep 02 2005 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Buy | M | 9.66 | 30,000 | 289,689 | 623,178 | 593.2 K to 623.2 K (+5.06 %) |
Sep 01 2005 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Option Exercise | M | 9.66 | 10,000 | 96,563 | 85,416 | |
Sep 01 2005 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Sell | S | 26.24 | 10,000 | 262,350 | 593,178 | 603.2 K to 593.2 K (-1.66 %) |
Sep 01 2005 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Buy | M | 9.66 | 10,000 | 96,563 | 603,178 | 593.2 K to 603.2 K (+1.69 %) |
Sep 08 2005 | PDLI | PDL BIOPHARMA, INC ... | QUEEN CARY L | Director | Sell | S | 30.00 | 54,000 | 1,620,000 | 1,972,800 | 2 M to 2 M (-2.66 %) |
Aug 23 2005 | PDLI | PDL BIOPHARMA, INC ... | QUEEN CARY L | Director | Option Exercise | M | 6.63 | 10,000 | 66,250 | 40,000 | |
Aug 23 2005 | PDLI | PDL BIOPHARMA, INC ... | QUEEN CARY L | Director | Sell | S | 26.31 | 10,000 | 263,065 | 2,026,800 | 2 M to 2 M (-0.49 %) |
Aug 23 2005 | PDLI | PDL BIOPHARMA, INC ... | QUEEN CARY L | Director | Buy | M | 6.63 | 10,000 | 66,250 | 2,036,800 | 2 M to 2 M (+0.49 %) |
Aug 17 2005 | PDLI | PDL BIOPHARMA, INC ... | QUEEN CARY L | Director | Option Exercise | M | 6.63 | 10,000 | 66,250 | 50,000 | |
Aug 17 2005 | PDLI | PDL BIOPHARMA, INC ... | QUEEN CARY L | Director | Sell | S | 26.00 | 10,000 | 260,000 | 2,026,800 | 2 M to 2 M (-0.49 %) |
Aug 17 2005 | PDLI | PDL BIOPHARMA, INC ... | QUEEN CARY L | Director | Buy | M | 6.63 | 10,000 | 66,250 | 2,036,800 | 2 M to 2 M (+0.49 %) |
Aug 31 2005 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Option Exercise | M | 9.66 | 20,000 | 193,126 | 95,416 | |
Aug 31 2005 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Sell | S | 26.40 | 10,000 | 264,000 | 593,178 | 603.2 K to 593.2 K (-1.66 %) |
Aug 31 2005 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Sell | S | 26.30 | 5,000 | 131,479 | 603,178 | 608.2 K to 603.2 K (-0.82 %) |
Aug 31 2005 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Sell | S | 26.30 | 5,000 | 131,500 | 608,178 | 613.2 K to 608.2 K (-0.82 %) |
Aug 31 2005 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Sell | S | 26.08 | 10,000 | 260,758 | 613,178 | 623.2 K to 613.2 K (-1.60 %) |
Aug 31 2005 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Buy | M | 9.66 | 20,000 | 193,126 | 623,178 | 603.2 K to 623.2 K (+3.32 %) |
Aug 09 2005 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Option Exercise | M | 9.66 | 44,584 | 430,516 | 115,416 | |
Aug 09 2005 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Sell | S | 27.90 | 4,584 | 127,894 | 603,178 | 607.8 K to 603.2 K (-0.75 %) |
Aug 09 2005 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Buy | M | 9.66 | 4,584 | 44,264 | 607,762 | 603.2 K to 607.8 K (+0.76 %) |
Aug 09 2005 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Sell | S | 27.31 | 610 | 16,659 | 603,178 | 603.8 K to 603.2 K (-0.10 %) |
Aug 09 2005 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Sell | S | 27.80 | 30,000 | 834,060 | 603,788 | 633.8 K to 603.8 K (-4.73 %) |
Aug 09 2005 | PDLI | PDL BIOPHARMA, INC ... | KORN LAURENCE JAY | Director | Sell | S | 27.40 | 40,000 | 1,096,100 | 633,788 | 673.8 K to 633.8 K (-5.94 %) |